Anne Marie Cook serves as Chief Legal Officer and Secretary at Phathom Pharmaceuticals Inc., a biopharmaceutical company focused on developing and commercializing innovative therapies for gastrointestinal diseases, including its flagship product VOQUEZNA for erosive esophagitis and Helicobacter pylori infection. In this dual role, she leads the company's legal strategy, overseeing regulatory compliance, intellectual property protection, corporate governance, risk management, and commercial contracts. As Corporate Secretary, she facilitates board operations, shareholder relations, and ensures adherence to high standards of corporate ethics and transparency. With over two decades of experience in the pharmaceutical industry, Cook previously held senior legal positions at Takeda Pharmaceuticals America, where she served as Senior Director of Legal, supporting global commercial operations, product launches, mergers and acquisitions, and FDA regulatory matters. Earlier in her career, she was Vice President of Legal at Salix Pharmaceuticals (acquired by Valeant, now Bausch Health) and held progressively senior roles at GlaxoSmithKline, honing her expertise in life sciences transactions, litigation, and compliance programs. Cook's notable achievements include guiding multiple blockbuster product launches, structuring complex strategic partnerships, and implementing robust compliance frameworks that have mitigated risks in highly regulated environments. A graduate of Villanova University Charles Widger School of Law (J.D.) and the University of Pennsylvania (B.A.), she brings strategic foresight and deep industry knowledge to Phathom, playing a pivotal role in the company's successful commercialization efforts and sustained growth.